Doctor profile · Federal record
Dr. Ali Moussa, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Tulsa, OK
- NPI 1548207814
- Accepts Medicare
- MIPS 82.5 / 100 · 2023
- 32 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12697 E 51St St
Tulsa, OK 741466236
(918) 505-3200
fax (918) 505-3253
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- September 2, 2020
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Oklahoma #21439
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548207814. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
104,012
Distinct HCPCS
10
Medicare allowed
$1,985,474
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 26,250 | 27 | $1 | |
J9267 |
Injection, paclitaxel, 1 mg | 13,590 | 19 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 12,120 | 14 | $28 | |
J9271 |
Injection, pembrolizumab, 1 mg | 11,400 | 19 | $54 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 5,600 | 30 | $5 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,800 | 43 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 3,770 | 20 | $1 | |
J1449 |
Injection, eflapegrastim-xnst, 0.1 mg | 2,904 | 15 | $32 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,820 | 82 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,952 | 745 | $8 |
In context: peer comparison
Among 18 peers in Tulsa Hematology & Oncology Physician, average services per provider: 1,283. This provider delivers 81× the peer median.Open Payments
Industry payments received
All-time total
$540
Transactions
22
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 2 | $140.31 | |
| BeiGene USA, INC. | 4 | $80.87 | |
| Bayer Healthcare Pharmaceuticals INC. | 2 | $52.35 | |
| Pfizer INC. | 2 | $39.17 | |
| Daiichi Sankyo INC. | 2 | $39.08 | |
| Novartis Pharmaceuticals Corporation | 2 | $38.82 | |
| GlaxoSmithKline, LLC. | 2 | $33.78 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $28.96 | |
| Aveo Pharmaceuticals, INC. | 1 | $21.14 | |
| Lilly USA, LLC | 1 | $19.48 | |
| Incyte Corporation | 1 | $16.95 | |
| Genentech USA, INC. | 1 | $15.64 | |
| Astellas Pharma US INC | 1 | $13.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,233
Patients
660
Total drug cost
$3,095,212
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 412 | 86 | $18,298 |
| Ondansetron Hcl | Generic | 198 | 107 | $5,485 |
| Prochlorperazine Maleate | Generic | 189 | 93 | $2,394 |
| Levothyroxine Sodium | Generic | 177 | 44 | $2,219 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 174 | 60 | $3,451 |
| Alendronate Sodium | Generic | 168 | 33 | $1,897 |
| Potassium Chloride | Generic | 145 | 37 | $3,585 |
| Prednisone | Generic | 138 | 38 | $1,049 |
| Dexamethasone | Generic | 134 | 46 | $3,287 |
| Duloxetine Hcl | Generic | 105 | 20 | $1,264 |
Hospital affiliations
Frequently asked questions
What is Dr. Ali Moussa's medical specialty?
Dr. Ali Moussa practices Hematology & Oncology Physician in Tulsa, OK.
Where does Dr. Ali Moussa practice?
Dr. Ali Moussa practices at 12697 E 51St St, Tulsa, OK 741466236. Office phone: 9185053200.
What is Dr. Ali Moussa's NPI?
Dr. Ali Moussa's National Provider Identifier (NPI) is 1548207814, issued by NPPES.
Does Dr. Ali Moussa accept Medicare assignment?
Yes. Dr. Ali Moussa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ali Moussa commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, paclitaxel, 1 mg (HCPCS J9267); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.